Only enteral diet on the market with Bifidobacterium lactis BPL1 

A complete, normocaloric and high-protein diet specially designed to cover the nutritional needs of surgical patients with energy restrictions.

Gut flora, or gut microbiota, is the set of micro-organisms and bacteria that live in our gut.

Our flora is made up of 100 billion bacteria that bring about multiple benefits; therefore, it is imperative for us to keep that bacteria balanced and in good condition to ensure good health.

Every package of Bi1 bificare contains 3.3 billion BPL1 bifidobacteria. These bifidobacteria help to enhance the state of your gut flora and to improve cardiovascular risk factors (arterial hypertension, glucose metabolism disorders, abdominal fat, etc.)

- Improves  microbiota, increasing Akkermansia spp.1


- Improves metabolic parameters. Contributes to reducing diastolic blood pressure and insulin resistance index (HOMA-IR).1


- Improves anthropometric parameters and body composition parameters. Contributes to reducing BMI, waist circumference, and visceral fat.1


- Antioxidant and anti-inflammatory properties at the cellular level.1-4
 

Scientifically proven evidence:

- Fiber (70% soluble – 30% insoluble).

- EPA and DHA (anti-inflammatory properties).

- L-leucine (strengthens the synthesis of muscle mass).

- Proteins with a high biological value and high digestibility.
- Complex carbohydrates (maltodextrin with a low glycemic index).

- Extra virgin olive oil (cardiovascular, antioxidant, and anti-inflammatory benefits).
 

Additionally, it contains:

1.    Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial. Pedret A, Valls RM, Calderón-Pérez L, Llauradó E, Companys J, Pla-Pagà L, Moragas A, Martín-Luján F, Ortega Y, Giralt M, Caimari A, Chenoll E, Genovés S, Martorell P, Codoñer FM, Ramón D, Arola L, Solà R. Int J Obes (Lond). 2019 Sep;43(9):1863-1868. doi: 10.1038/s41366-018-0220-0. 
2.    Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats. Carreras NL, Martorell P, Chenoll E, Genovés S, Ramón D, Aleixandre A. Benef Microbes. 2018 Jun 15;9(4):629-641. doi: 10.3920/BM2017.0141. 
3.    Probiotic Strain Bifidobacterium animalis subsp. lactis CECT 8145 Reduces Fat Content and Modulates Lipid Metabolism and Antioxidant Response in Caenorhabditis elegans. Martorell P, Llopis S, González N, Chenoll E, López-Carreras N, Aleixandre A, Chen Y, Karoly ED, Ramón D, Genovés S. J Agric Food Chem. 2016 May 4;64(17):3462-72. doi: 10.1021/acs.jafc.5b05934. Epub 2016 Apr 19.
4.    Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas. Spanish Patent and Trademark Office. Publication number: 2 526 986. Consulted on 9/10/2019 at https://patents.google.com/patent/WO2015007941A1/es

 

“In accordance with article 15 of the Spanish Law on Guarantees and Rational Use of Medicines and Healthcare products, the information set out in the following sections is aimed for healthcare professionals who carry out their activities in Spain and are subject to Spanish law.”
“Under no circumstances does ADVENTIA assume any liability for any injury that might result from illegal or improper use of this website. Both access to this web site and the use made of the information contained herein is the exclusive responsibility of the user.”